Tuberculosis and Other Mycobacterial Infections

  • Authors: Richard E. Chaisson, MD (More Info)
  • Editors in Chief: Daniel R. Kuritzkes, MD; Joseph J. Eron, Jr., MD
  • Last Reviewed: 3/30/17 (What's New)

Summary

  • Patients starting TB treatment should receive a medication review for drug-drug interactions at baseline and routinely thereafter, particularly patients receiving rifamycins[Nahid 2016; Liverpool HIV Drug Interactions]
  • Baseline laboratory analyses should include liver function tests, serum creatinine level measurements, and complete blood cell counts with platelet counts and CD4+ cell counts[Nahid 2016]

Action required